Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Empowered patients improve outcomes

April 27, 2018 | patient activation, patient empowerment, patient engagement 

This white paper co-authored by our own Caroline Benson and Guy Yeoman, MediPaCe, discusses why non-adherence is occurring, how patients’ can be better engaged with their conditions and treatments and provides examples and results of patient engagement in action.


Non-adherence to medication is not a new global healthcare concern but with more people living with long-term conditions the problem is increasing[1]. A difficult problem to solve, this multifaceted phenomenon[2] can have a variety of negative effects for society and for the individuals involved.  

This white paper co-authored by our own Caroline Benson and Guy Yeoman, MediPaCe, discusses why non-adherence is occurring, how patients’ can be better engaged with their conditions and treatments and provides examples and results of patient engagement in action.  

Access the white paper here: 
http://cuttsyandcuttsy.com/blogs/Apr-2018/empowering-patients

1. Clyne W, et al. BMJ Open 2016; 6:e009610.
2. Kvarnström K, et al. BMJ Open 2018;8: e015332. doi:10.1136/bmjopen-2016-015332

This content was provided by Cuttsy + Cuttsy

Company Details

Cuttsy and Cuttsy Logo

Cuttsy + Cuttsy

Email
Website

 Latest Content from  Cuttsy + Cuttsy 

Another year, another B!

Louise Jones, Cuttsy+Cuttsy's Sustainability Officer reflects on their latest year of carbon reporting through CDP and on achieving another B rating.

Jon Hume Joins Cuttsy+Cuttsy as New Commercial Director

Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.

Clinical trial considerations: Why supporting HCPs matters...

When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone.

Clinical trial considerations: Why diversity matters...

Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here's why diversity matters...

Clinical trial considerations: Why digital matters...

Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.

Clinical trials explained: Why imagery matters...

Recruiting patients for clinical trials is one of pharma's greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the...

Clinical trials explained: Why health literacy matters...

Clinical trial recruitment can be a challenge. By applying the principles of health literacy to all materials, we can support people to make an informed choice about whether to take...

Clinical trials explained: Why iconography matters...

Icons serve as a useful form of alternative communication. We spend a lot of time developing icons for healthcare communications. Find out how we use iconography to elevate clinical trial...

Cuttsy+Cuttsy appoints Harriet Karia as Managing Director

Cuttsy+Cuttsy is pleased to announce the appointment of Harriet Karia as its first Managing Director.

Using generative AI in healthcare comms - our promise to our clients

It’s safe to say one of the hottest topics of 2023 has been ChatGPT and the launch of other Generative AI-driven applications. So, we’re sharing our promises, so that when...